Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 8:1-8.
doi: 10.1007/s44174-023-00063-2. Online ahead of print.

Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector

Bangul Khan  1   2 , Hajira Fatima  3 , Ayatullah Qureshi  3 , Sanjay Kumar  4 , Abdul Hanan  3 , Jawad Hussain  2 , Saad Abdullah  2   5
Affiliations
Review

Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector

Bangul Khan et al. Biomed Mater Devices. .

Abstract

Artificial intelligence (AI) has the potential to make substantial progress toward the goal of making healthcare more personalized, predictive, preventative, and interactive. We believe AI will continue its present path and ultimately become a mature and effective tool for the healthcare sector. Besides this AI-based systems raise concerns regarding data security and privacy. Because health records are important and vulnerable, hackers often target them during data breaches. The absence of standard guidelines for the moral use of AI and ML in healthcare has only served to worsen the situation. There is debate about how far artificial intelligence (AI) may be utilized ethically in healthcare settings since there are no universal guidelines for its use. Therefore, maintaining the confidentiality of medical records is crucial. This study enlightens the possible drawbacks of AI in the implementation of healthcare sector and their solutions to overcome these situations.

Keywords: Artificial intelligence; Clinical practices; Health sector; IoT; Machine learning.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestAuthors have no conflict of interest.

References

    1. Chan HCS, Shan H, Dahoun T, Vogel H, Yuan S. Advancing drug discovery via artificial intelligence. Trends Pharmacol. Sci. 2019;40(8):592–604. doi: 10.1016/j.tips.2019.06.004. - DOI - PubMed
    1. Cruciger O, Schildhauer TA, Meindl RC, Tegenthoff M, Schwenkreis P, Citak M, Aach M. Impact of locomotion training with a neurologic controlled hybrid assistive limb (HAL) exoskeleton on neuropathic pain and health related quality of life (HRQoL) in chronic SCI: a case study. Disabil. Rehabil. Assist. Technol. 2016;11(6):529–534. - PubMed
    1. Díaz Ó, Dalton JAR, Giraldo J. Artificial intelligence: a novel approach for drug discovery. Trends Pharmacol. Sci. 2019;40(8):550–551. doi: 10.1016/j.tips.2019.06.005. - DOI - PubMed
    1. J. Habermann, Psychological impacts of COVID-19 and preventive strategies: A review. (2021).
    1. Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol. Sci. 2019;40(8):577–591. doi: 10.1016/j.tips.2019.05.005. - DOI - PubMed

LinkOut - more resources